Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析

◆英語タイトル:Sorrento Therapeutics Inc (SRNE) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1639
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:45
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥17,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥35,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥52,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Sorrento Therapeutics Inc (SRNE) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Sorrento Therapeutics Inc (Sorrento), formerly QuikByte Software Inc, is a biopharmaceutical company. It focuses on developing therapeutics for the treatment of cancer, osteoarthritis pain as well as infectious and immunological related diseases. The company’s immuno-oncology (I-O) portfolio comprises of a broad fully human antibody library (G-MAB), clinical stage chimeric antigen receptor-T cells (CAR-T), antibody-drug conjugates (ADC), Dimeric Antigen Receptor T cells (DAR-T) and an oncolytic virus (Sephrehvir). It markets its only approved product, ZTlido (lidocaine topical system 1.8%), in the US for the treatment of postherpetic neuralgia (PHN). The company works in collaboration with biopharmaceutical companies and academic institutions to develop novel immunotherapies. Sorrento is headquartered in San Diego, California, the US.

Sorrento Therapeutics Inc Key Recent Developments

Apr 01,2020 Sorrento forms alliance for preclinical testing of Covid-19 drugs
Jan 29,2020 Sorrento and Celularity to initiate emergency Allogeneic Natural Killer (NK) Cell Therapy development for Coronavirus Infection

Dec 16,2019 Sorrento announces Dr. Robin Smith as new member of the Board of Directors
Dec 09,2019 Sorrento announces new board member

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Sorrento Therapeutics Inc – Key Facts
Sorrento Therapeutics Inc – Key Employees
Sorrento Therapeutics Inc – Key Employee Biographies
Sorrento Therapeutics Inc – Major Products and Services
Sorrento Therapeutics Inc – History
Sorrento Therapeutics Inc – Company Statement
Sorrento Therapeutics Inc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture
Section 2 – Company Analysis
Company Overview
Sorrento Therapeutics Inc – Business Description
Business Segment: Scilex
Overview
Performance
Business Segment: Sorrento Therapeutics
Overview
Performance
Sorrento Therapeutics Inc – Corporate Strategy
Sorrento Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Sorrento Therapeutics Inc – Strengths
Sorrento Therapeutics Inc – Weaknesses
Sorrento Therapeutics Inc – Opportunities
Sorrento Therapeutics Inc – Threats
Sorrento Therapeutics Inc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sorrento Therapeutics Inc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Apr 01, 2020: Sorrento forms alliance for preclinical testing of Covid-19 drugs
Jan 29, 2020: Sorrento and Celularity to initiate emergency Allogeneic Natural Killer (NK) Cell Therapy development for Coronavirus Infection
Dec 16, 2019: Sorrento announces Dr. Robin Smith as new member of the Board of Directors
Dec 09, 2019: Sorrento announces new board member
Nov 12, 2019: Sorrento CEO to present at upcoming investor conferences
Apr 16, 2019: Sorrento establishes business unit to address market opportunity for proprietary water soluble cannabidiol formulations
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Sorrento Therapeutics Inc, Key Facts
Sorrento Therapeutics Inc, Key Employees
Sorrento Therapeutics Inc, Key Employee Biographies
Sorrento Therapeutics Inc, Major Products and Services
Sorrento Therapeutics Inc, History
Sorrento Therapeutics Inc, Subsidiaries
Sorrento Therapeutics Inc, Joint Venture
Sorrento Therapeutics Inc, Key Competitors
Sorrento Therapeutics Inc, Ratios based on current share price
Sorrento Therapeutics Inc, Annual Ratios
Sorrento Therapeutics Inc, Annual Ratios (Cont...1)
Sorrento Therapeutics Inc, Annual Ratios (Cont...2)
Sorrento Therapeutics Inc, Interim Ratios
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Sorrento Therapeutics Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Sorrento Therapeutics Inc, Performance Chart (2015 - 2019)
Sorrento Therapeutics Inc, Ratio Charts
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Sorrento Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[Sorrento Therapeutics Inc (SRNE):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • AutoGenomics Inc-医療機器分野:企業M&A・提携分析
    Summary AutoGenomics Inc (AutoGenomics) is a provider of automated technologies for test processes inherent in genetic analysis. The company offers infiniti systems and FDA cleared products and RUO products. Its infiniti system is designed for processing AutoGenomics' unique proprietary BioFilmChip …
  • Gulf Oil Limited Partnership:企業の戦略・SWOT・財務情報
    Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report Summary Gulf Oil Limited Partnership - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Franz Haniel & Cie. GmbH:企業の戦略的SWOT分析
    Franz Haniel & Cie. GmbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Bangchak Corporation PCL (BCP):企業の財務・戦略的SWOT分析
    Bangchak Corporation PCL (BCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Schaffer Corporation Limited (SFC):企業の財務・戦略的SWOT分析
    Schaffer Corporation Limited (SFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Integra Holdings Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Integra Holdings Ltd (Integra Holdings), a subsidiary of Yissum Research Development Company of the Hebrew University of Jerusalem Ltd, is a healthcare investment company that invests in biopharmaceutical companies with products in clinical and pre-clinical stages of development. The company …
  • Texas Instruments Incorporated:企業の戦略・SWOT・財務情報
    Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report Summary Texas Instruments Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Pentair Plc (PNR):電力:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • Radiomedix Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that develops and commercializes radiopharmaceuticals for diagnosis and therapy of cancer. The company’s products include radioisotopes, fully automated synthesizers, semi-automated synthesizers, GMP cassettes and consumables, smartmedix …
  • Caladrius Biosciences Inc (CLBS)-医療機器分野:企業M&A・提携分析
    Summary Caladrius Biosciences Inc (Caladrius), formerly NeoStem Inc is a clinical stage development company that develops and manufactures cell therapy products. The company’s products are based on its proprietary technologies such as Dendritic Cell-Tumor Cell technology; CD34 technology; and T Regu …
  • Northbridge Financial Corporation:企業の戦略的SWOT分析
    Northbridge Financial Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • Modiin Energy Limited Partnership (MDIN.L):石油・ガス:M&Aディール及び事業提携情報
    Summary Modiin Energy Limited Partnership (Modiin Energy) is an oil and gas company that offers crude oil exploration programs. The company operates in the exploration and development of oil and natural gas properties. It owns and operates five assets such as Shimshon, Daniel east, Daniel west, Grap …
  • Pantheon Resources plc (PANR):企業の財務・戦略的SWOT分析
    Summary Pantheon Resources Plc (Pantheon Resources) is an oil and gas exploration and production company. It explores, develops and produces crude oil and natural gas resource properties. The company invests in oil and gas exploration and development. It operates hydrocarbon producing basins onshore …
  • Atrium Health:企業の戦略的SWOT分析
    Atrium Health - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Haemonetics Corp (HAE)-医療機器分野:企業M&A・提携分析
    Summary Haemonetics Corp (Haemonetics) is a healthcare company, which offers blood management technology and software solutions. The company’s portfolio consists of integrated devices, information management software, and consulting services for improving clinical outcomes. It also offers a comprehe …
  • Mirvac Group:企業のM&A・事業提携・投資動向
    Mirvac Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Mirvac Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • ContourGlobal plc (GLO):電力:M&Aディール及び事業提携情報
    Summary ContourGlobal plc (ContourGlobal) formerly ContourGlobal Ltd, is an energy company. It develops, acquires, owns, and operates wholesale power generation assets under long-term contracts. The company creates asset by taking them through the permitting, financing, and construction processes, a …
  • Origin Energy Ltd (ORG):企業の財務・戦略的SWOT分析
    Origin Energy Ltd (ORG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • GR. Sarantis S.A.:企業の戦略・SWOT・財務分析
    GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report Summary GR. Sarantis S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • EnBW Energie Baden-Wuerttenberg AG:企業のM&A・事業提携・投資動向
    EnBW Energie Baden-Wuerttenberg AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's EnBW Energie Baden-Wuerttenberg AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆